What is the life expectancy of someone with Cholesteryl Ester Storage Disease?

Cholesteryl Ester Storage Disease (CESD) is a rare genetic disorder that affects the body's ability to break down and process fats. It is caused by mutations in the LIPA gene, which leads to a deficiency of the lysosomal enzyme called lysosomal acid lipase (LAL). This enzyme is responsible for breaking down cholesteryl esters and triglycerides in the body.

The severity and progression of CESD can vary widely among individuals. Some people may have mild symptoms and a relatively normal life expectancy, while others may experience more severe symptoms and complications that can impact their lifespan.

Common symptoms of CESD include hepatomegaly (enlarged liver), splenomegaly (enlarged spleen), elevated liver enzymes, and dyslipidemia (abnormal lipid levels). These symptoms can manifest in childhood or adulthood, and the age of onset can influence the disease progression.

Without treatment, CESD can lead to progressive liver disease, including liver fibrosis, cirrhosis, and liver failure. It can also cause cardiovascular complications, such as atherosclerosis and cardiovascular disease. These complications can significantly impact the overall health and life expectancy of individuals with CESD.

Early diagnosis and appropriate management are crucial in improving outcomes for individuals with CESD. Enzyme replacement therapy (ERT) with sebelipase alfa has shown promising results in reducing liver size, improving liver function, and decreasing lipid levels in patients with CESD. ERT can help slow down the progression of liver disease and potentially improve life expectancy.

It is important to note that the long-term prognosis for individuals with CESD can vary depending on various factors, including the severity of symptoms, age of onset, and response to treatment. Regular monitoring, close medical management, and lifestyle modifications, such as a low-fat diet, are essential in managing the disease and optimizing outcomes.

In conclusion, the life expectancy of someone with Cholesteryl Ester Storage Disease can be influenced by various factors, and it is difficult to provide a specific range. However, early diagnosis, appropriate management, and advancements in treatment options like enzyme replacement therapy can help improve outcomes and potentially extend the lifespan of individuals with CESD.